Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Clearbridge Health Ltd. (DE:5C6)
FRANKFURT:5C6
Holding DE:5C6?
Track your performance easily
5C6 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.01 - €0.01
Previous Close€0.01
Volume0.00
Average Volume (3M)N/A
Market Cap
€5.26M
Enterprise Value€7.46M
Total Cash (Recent Filing)S$11.50M
Total Debt (Recent Filing)S$9.43M
Price to Earnings (P/E)―
Beta-0.21
Next Earnings
Feb 28, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.46
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Clearbridge Health Ltd. News
PremiumCompany Announcements
Clearbridge Health Adjusts Convertible Bonds Amid Rights Issue
PremiumCompany Announcements
Clearbridge Health’s Rights Issue Sees Strong Investor Interest
PremiumCompany Announcements
Clearbridge Health’s EGM Highlights and Voting Outcomes
PremiumCompany Announcements
Clearbridge Health Updates Shareholding Details and Rights IssuePremiumCompany Announcements
Clearbridge Health Launches Major Rights Issue in Singapore
PremiumCompany Announcements
Clearbridge Health Updates Investors on Subsidiary Correction
PremiumCompany Announcements
Clearbridge Health Announces New Secretaries
PremiumCompany Announcements
Clearbridge Health Ltd. Holds Successful AGMOptions Prices
Currently, No data available
---
Ownership Overview
5C6 FAQ
What was Clearbridge Health Ltd.’s price range in the past 12 months?
Clearbridge Health Ltd. lowest stock price was €0.01 and its highest was €0.01 in the past 12 months.
What is Clearbridge Health Ltd.’s market cap?
Currently, no data Available
When is Clearbridge Health Ltd.’s upcoming earnings report date?
Clearbridge Health Ltd.’s upcoming earnings report date is Feb 28, 2025 which is in 67 days.
How were Clearbridge Health Ltd.’s earnings last quarter?
Clearbridge Health Ltd. released its earnings results on Nov 14, 2024. The company reported >-€0.001 earnings per share for the quarter, missing the consensus estimate of N/A by >-€0.001.
Is Clearbridge Health Ltd. overvalued?
According to Wall Street analysts Clearbridge Health Ltd.’s price is currently Overvalued.
Does Clearbridge Health Ltd. pay dividends?
Clearbridge Health Ltd. does not currently pay dividends.
What is Clearbridge Health Ltd.’s EPS estimate?
Clearbridge Health Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Clearbridge Health Ltd. have?
Clearbridge Health Ltd. has 1,859,224,000 shares outstanding.
What happened to Clearbridge Health Ltd.’s price movement after its last earnings report?
Clearbridge Health Ltd. reported an EPS of >-€0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -50%.
Which hedge fund is a major shareholder of Clearbridge Health Ltd.?
Currently, no hedge funds are holding shares in DE:5C6
---
Clearbridge Health Ltd. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
-137.86%
Trailing 12-Months
Asset Growth
-64.15%
Trailing 12-Months
Company Description
Clearbridge Health Ltd.
Clearbridge Health Ltd provides health care services. It is an integrated healthcare group with end-to-end diagnostic abilities, deploying non-invasive tests to identify and manage illness. The segments of the company are Strategic investments; Healthcare systems; Medical clinics; and Corporate segment. It derives key revenue from the Healthcare systems and Medical clinics. The Healthcare systems segment involves the provision of diagnostic services and manufacturing of and research and development on diagnostic related products, and provision of renal care services by partnering with medical device equipment manufacturers and hospitals. The Medical clinics segment involves the provision of general medical and clinical services. The group has a business presence in all over the world.
---
---